Pyrotinib after trastuzumab-based adjuvant therapy in HER2- positive breast cancer: a single-arm, open, exploratory research
Latest Information Update: 03 Dec 2020
At a glance
- Drugs Pyrotinib (Primary)
- Indications Advanced breast cancer; Early breast cancer; HER2 positive breast cancer
- Focus Therapeutic Use
- 03 Dec 2020 New trial record